Gastritis News and Research

RSS
Gastritis is not a single disease, but several different conditions that all have inflammation of the stomach lining. Gastritis can be caused by drinking too much alcohol, prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen, or infection with bacteria such as Helicobacter pylori (H. pylori). Sometimes gastritis develops after major surgery, traumatic injury, burns, or severe infections. Certain diseases, such as pernicious anemia, autoimmune disorders, and chronic bile reflux, can cause gastritis as well.
S. thermophilus CRL 1190-fermented milk effective in therapeutic treatment of chronic gastritis: Research

S. thermophilus CRL 1190-fermented milk effective in therapeutic treatment of chronic gastritis: Research

Gelatinase B expression enhanced in gastric cancer compared to normal gastric mucosa

Gelatinase B expression enhanced in gastric cancer compared to normal gastric mucosa

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Insight into mechanism H. pylori uses to evade the immune system

Insight into mechanism H. pylori uses to evade the immune system

Study shows lactobacillus is effective in improving H. pylori-infected diseases

Study shows lactobacillus is effective in improving H. pylori-infected diseases

Role of H. pylori in autoimmune atrophic gastritis

Role of H. pylori in autoimmune atrophic gastritis

ZEGERID OTC approval triggers $20M milestone payment to Santarus

ZEGERID OTC approval triggers $20M milestone payment to Santarus

Tips to prevent hangover during holiday season

Tips to prevent hangover during holiday season

FDA approves Santarus’ NDA for immediate-release prescription tablet product

FDA approves Santarus’ NDA for immediate-release prescription tablet product

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

Study: Short-term use of COX-2 inhibitors may help prevent gastric cancer

Study: Short-term use of COX-2 inhibitors may help prevent gastric cancer

Lifestyle and genetic factors are considered to play a major role in "Asian paradox"

Lifestyle and genetic factors are considered to play a major role in "Asian paradox"

PillCam ESO accurately identifies patients with upper gastrointestinal bleeding

PillCam ESO accurately identifies patients with upper gastrointestinal bleeding

Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers

Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers

Santarus to present results from two investigator-initiated studies with ZEGERID at 2009 ACG meeting

Santarus to present results from two investigator-initiated studies with ZEGERID at 2009 ACG meeting

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

GI tract conditions can occur in sleep apnea patients

GI tract conditions can occur in sleep apnea patients

Study aims to discover effective antibiotics to fight against hard-to-treat microbes

Study aims to discover effective antibiotics to fight against hard-to-treat microbes